Truace
Subscribe

Integration of liquid chromatography-tandem mass spectrometry into total laboratory automation: technical challenges and clinical advantages

The clinical laboratory is undergoing a paradigm shift toward the integration of liquid chromatography-tandem mass spectrometry(MS) into Total Laboratory Automation workflows. While historically relegated to specialized satellite units due to manual pre-analytical requirements, recent technological advancements have enabled the development of fully automated, 'sample-to-result' MS modules. This review provides an authoritative analysis of the technical integration of systems such as the Roche cobas® i 601 and Sh…

By the Truvace desk1 min read1 sourcePeer-reviewedTRV-2026-1319· cite & verify
Integration of liquid chromatography-tandem mass spectrometry into total laboratory automation: technical challenges and clinical advantages
"Gas Chromatography Laboratory" by Hey Paul from Sacramento, CA, USA is licensed under CC BY 2.0. To view a copy of this license, visit https://creativecommons.org/licenses/by/2.0/.

In brief

Published October 2026, this review examines integration of liquid chromatography-tandem mass spectrometry into Total Laboratory Automation, highlighting fully automated sample-to-result modules such as Roche cobas i 601 and Shimadzu CLAM-2040 and the role of intelligent middleware and AI-assisted algorithms for data validation and monitoring.

The integration matters because it moves MS from low-throughput specialty testing to continuous high-throughput routine use, with claimed impact on diagnostic accuracy for low-concentration analytes in endocrinology and therapeutic drug monitoring, though the abstract does not report measured patient outcomes or comparative performance data.

Main points

  1. Review analyzes fully automated sample-to-result MS modules including Roche cobas i 601 and Shimadzu CLAM-2040 moving from satellite units to core labs.
  2. Intelligent middleware with AI-assisted algorithms provides standardized data validation, quality control tracking, and real-time operational monitoring.
  3. Transition from batch-based processing to continuous automated streams positions MS as high-throughput tool for routine diagnostics.

The gain

Integration of artificial intelligence-assisted middleware into total laboratory automation enables standardized validation and improves diagnostic accuracy for low-concentration analytes in endocrinology and therapeutic drug monitoring.

The rundown

The review describes a shift from manual pre-analytical MS in specialized satellite units to fully automated sample-to-result modules integrated into Total Laboratory Automation workflows.

It focuses on technical integration of commercial systems Roche cobas i 601 and Shimadzu CLAM-2040 and the use of intelligent middleware for validation, QC tracking, and operational monitoring.

Sources

  1. Peer-reviewedClinical Biochemistry2026-10-03

The debate